JPH035391B2 - - Google Patents
Info
- Publication number
- JPH035391B2 JPH035391B2 JP21882582A JP21882582A JPH035391B2 JP H035391 B2 JPH035391 B2 JP H035391B2 JP 21882582 A JP21882582 A JP 21882582A JP 21882582 A JP21882582 A JP 21882582A JP H035391 B2 JPH035391 B2 JP H035391B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- general formula
- group
- oxazole
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
本発明は下記一般式(I)で表わされる新規な
オキサゾール誘導体に関する。
〔式中、R1はアリール基、又は窒素原子を1若
しくは2個含有し置換基として低級アルキル基を
有し若しくは有しない5又は6員環の芳香族複素
環基を、R2は低級アルキル基を、は0又は1
若しくは2の整数を意味する。〕
上記一般式(I)中、R1で表わされるアリー
ル基としてはフエニル基、ナフチル基等を、又、
窒素原子を1若しくは2個含有する5又は6員環
の芳香族複素環基としては、ピラゾリル基、イミ
ダゾリル基、ピリジル基等を具体的に例示するこ
とができる。又、R1及びR2における低級アルキ
ル基としては炭素数1〜6のアルキル基、例えば
メチル、エチル、プロピル、イソプロピル、ブチ
ル、sec−ブチル、tert−ブチル、ペンチル、ヘ
キシル基等の直鎖状又は分枝状のアルキル基を示
すことができる。
本発明の一般式(I)で表わされる化合物は文
献未記載の新規化合物であり、例えば抗菌、抗バ
クテリア作用を有し医薬として有用な化合物であ
る。
本発明化合物(I)は例えば次に示す方法によ
り製造することができる。
<A法>
一般式
〔式中、Xはハロゲン原子を、R2は前記意味を
示す。〕で表わされる化合物と、一般式
R1S(O)mM ()
〔式中、Mはアルカリ金属原子又は銀原子を、
R1は前記意味を、mは0又は2の整数を示す。〕
で表わされる化合物を反応させる。
一般式()中、Xのハロゲン原子としては塩
素、臭素、ヨウ素原子を例示することができる。
一般式()で示される化合物は新規化合物であ
り、例えば下記一般式()で表わされる化合物
にハロゲン化剤を反応させて製造することができ
る。
〔式中、R2は前記意味を示す。〕
一般式()の化合物の製造法の詳細は後記参
考例において詳述する。又、一般式()におい
てMで表わされるアルカリ金属原子としてはリチ
ウム、ナトリウム、カリウム等を例示することが
できる。
化合物()および()の反応は好適には溶
媒中で行われる。溶媒としては反応に関与しない
限に特に限定されないが、一般にテトラハイドロ
フラン、ジオキサン、ジメトキシメタン等のエー
テル類、ジメチルスルホキサイド、ジメチルホル
ムアミド等の非プロトン性極性溶媒が挙げられ
る。化合物()および()の使用割合は適宜
選択すれば良く、一般的には化合物()に対
し、化合物()を1モル〜2モル当量使用する
のが好ましい。反応温度も適宜決定されるが、通
常は−20℃〜溶媒の還流温度程度が好ましく、一
般に約1〜24時間程度で反応は十分に完結する。
尚、反応は18−クラウン−6等のクラウンエーテ
ルを触媒量添加することにより促進される。
<B法>
一般式
〔式中、R1及びR2、は前記意味を示す。〕で表わ
される化合物を酸化剤と反応させることにより
一般式
〔式中、nは1又2の整数を、R1及びR2は前記
意味を示す。〕で表わされる本発明化合物を製造
できる。酸化剤としては各種のものを使用でき、
例えば過酢酸、過安息香酸、m−クロル過安息香
酸、過フタル酸等の過酸類、過酸化水素、オゾ
ン、過酸化ベンゾイル等の過酸化物、クロム酸、
過マンガン酸カリウム等の酸化金属類、次亜塩素
酸ナトリウム、メタ過ヨウ素酸ナトリウム等の次
亜ハロゲン酸類等が挙げられる。本反応は好適に
は溶媒中で行われる。溶媒としては反応に関与し
ないものであれば特に限定されないが、水、メタ
ノール、エタノール等のアルコール類、塩化メチ
レン等のハロゲン化炭化水素類が使用される。酸
化剤の使用割合は所望する本発明化合物に応じて
適宜に決定され限定的ではない。例えば一般式
()においてnが1であるスルホキサイド化合
物を製造する際には、一般式(V)で表わされる
化合物に対し、通常等モル量前後用いるのがよ
く、所望により若干過剰量使用することもでき
る。一方、一般式()においてnが2であるス
ルホン化合物を製造する際には、酸化剤の使用割
合は原料である一般式(V)の化合物に対し、約
2倍モル以上、通常約2〜3倍モル量とするのが
良い。
反応温度は適宜決定されるが、通常は−40℃〜
溶媒の沸点温度の範囲好ましく、反応時間は一般
に約1〜24時間程度で十分である。
反応終了後、目的化合物は公知の方法、例えば
抽出、再結晶、カラムクロマトグラフイー等によ
り容易に単離精製することできる。
以下、本発明を参考例及び実施例により詳細に
説明する。又、表1には本発明化合物及びその物
理化学的性質を示す。尚、各実施例における化合
物番号は表1に記載する番号と一致するものであ
る。
参考例
2−メチルオキサゾール−4−カルボン酸−t
−ブチルエステル7.32g、N−ブロモコハク酸イ
ミド10.68g、過酸化ベンゾイル60mgを四塩化炭
200ml中中に入れ、光照射下に4時間還流する。
冷後、不溶物を濾別し、濾液は水洗し、無水硫酸
ナトリウムで乾燥する。四塩化炭素を留去して得
られる残渣をシリカゲルカラムクロマトグラフイ
ーにて精製し、無色油状の2−ブロモメチル−オ
キサゾール−4−カルボン酸−t−ブチルエステ
ル4.35gを得る。
沸点 115〜118℃/0.1mmHg1
H−NMR(100MHz,CDCl3)
δ:1.58(9H,s,−COO−t−Bu)
4.47(2H,s,−CH2−)
8.14(1H,s,オキサゾール環5位プロト
ン)
MS(M+)261
C9H12NO3Brとし計算値m/e261.000
実測値m/e261.003
実施例 1
50%水素化ナトリウム670mg、乾燥テトラハイ
ドロフラン27mlの懸濁液に、窒素気流、氷冷下
に、ベンゼンチオール1.43mlを滴下する。同温で
5分間撹拌後、2−ブロモメチル−オキサゾール
−4−カルボン酸−t−ブチルエステル3.33g、
18−クラウン−6(100mg)を乾燥、テトラハイド
ロフラン10mlに溶解した溶液を上記反応液に滴下
し、同温で更に1.5時間撹拌する。テトラハイド
ロフランを留去し、残渣をジエチルエーテルで抽
出し、抽出液を無水硫酸ナトリウムで乾燥後、ジ
エチルエーテルを留去し、残渣をシリカゲルカラ
ムクロマトグラフイーにて精製し、得られた油状
物を石油エーテルより結晶化させ、この結晶をエ
ーテル−石油エーテルより再結晶し、融点64.5〜
65.5℃の無色微細針状結晶の2−フエニルチオメ
チル−オキサゾール−4−カルボン酸−t−ブチ
ルエステル(化合物1)3.1g(収率81%)を得た。
実施例 2
表1に記載の化合物4及び7を得るべく原料を
選んで、他は実施例1と同様にして化合物4及び
7を得た。
実施例 3
ベンゼンスルフイン酸ナトリウム3.2gに、室
温、窒素気流下に、2−ブロモメチル−オキサゾ
ール−4−カルボン酸−t−ブチルエステル2.1g
および18−クラウン−6(50mg)のアセトニトリ
ル溶液20mlを滴下し8時間撹拌する。アセトニト
リルを留去し残渣を塩化メチレンで抽出し、無水
硫酸ナトリウムで乾燥する。塩化メチレンを留去
し、残渣にエーテルを加え結晶を濾取し、エタノ
ールより再結晶し、融点180〜181℃の無色微細針
状結晶の2−ベンゼンスルホニルメチル−オキサ
ゾール−4−カルボン酸−t−ブチルエステル
(化合物3)1.99g(収率76%)を得た。
実施例 4
化合物1(846mg)及び塩化メチレン7mlの溶液
に窒素気流下、氷冷し、70%m−クロロ過安息香
酸752mgと塩化メチレン14mlの溶液を滴下し、同
温で30分間撹拌する。不溶物を濾去し、濾液は炭
酸水素ナトリウム水溶液で洗浄し、無水硫酸ナト
リウムで乾燥する。乾燥後、塩化メチレンを留去
し、得られた残渣をシリカゲルカラムクロマトグ
ラフイーにて精製し、得られ油状物をエーテルよ
り結晶化し、エーテル−石油エーテルより再結晶
し、融点129〜130℃の微細板状晶の2−ベンゼン
スルフイニルメチル−オキサゾール−4−カルボ
ン酸−t−ブチルエステル(化合物2)743mg
(収率83%)を得。
実施例 5
表1に記載の化合物5及び8を得るべく原料を
選んで、他は実施例4と同様の方法により化合物
5及び8を得た。
実施例 6
2−(ピリジル−2−チオメチル)−オキサゾー
ル−4−カルボン酸−t−ブチルエステル584mg
をジクロルメタン5mlに溶解し、これを窒素気流
下、氷冷し、m−クロロ過安息香酸1.08gをジク
ロルメタン20mlに溶解し溶液を滴下し、同温で30
分、さらに室温で5時間撹拌する。不溶物を濾去
し濾液を濃縮する。得られた残渣をシリカゲルカ
ラムクロマトグラフイーにて精製し、エタノール
より再結晶し、融点173〜174℃の無色微細針状晶
の2−(α−ピリジンスルホニルメチル)−オキサ
ゾール−4−カルボン酸−t−ブチルエステル
(化合物6)447mg(収率69%)を得た。
実施例 7
表1に記載の化合物3及び9を得るべく原料を
選んで、他は実施例6と同様の方法により化合物
3及び9を得た。
The present invention relates to a novel oxazole derivative represented by the following general formula (I). [In the formula, R 1 is an aryl group or a 5- or 6-membered aromatic heterocyclic group containing 1 or 2 nitrogen atoms and with or without a lower alkyl group as a substituent, and R 2 is a lower alkyl group. The group is 0 or 1
or an integer of 2. ] In the above general formula (I), the aryl group represented by R 1 includes a phenyl group, a naphthyl group, etc.
Specific examples of the 5- or 6-membered aromatic heterocyclic group containing one or two nitrogen atoms include a pyrazolyl group, an imidazolyl group, a pyridyl group, and the like. In addition, the lower alkyl group in R 1 and R 2 is an alkyl group having 1 to 6 carbon atoms, such as a linear group such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, hexyl group, etc. Alternatively, it can represent a branched alkyl group. The compound represented by the general formula (I) of the present invention is a new compound that has not been described in any literature, and is, for example, a compound that has antibacterial and antibacterial effects and is useful as a medicine. Compound (I) of the present invention can be produced, for example, by the method shown below. <Method A> General formula [In the formula, X represents a halogen atom, and R 2 represents the above meaning. ] and a compound represented by the general formula R 1 S(O)mM () [wherein M is an alkali metal atom or a silver atom,
R 1 has the above meaning, and m represents an integer of 0 or 2. ]
A compound represented by is reacted. In the general formula (), examples of the halogen atom of X include chlorine, bromine, and iodine atoms.
The compound represented by the general formula () is a new compound, and can be produced, for example, by reacting the compound represented by the following general formula () with a halogenating agent. [In the formula, R 2 has the above meaning. ] The details of the method for producing the compound of general formula () will be described in detail in Reference Examples below. Furthermore, examples of the alkali metal atom represented by M in the general formula () include lithium, sodium, potassium, and the like. The reaction of compounds () and () is preferably carried out in a solvent. The solvent is not particularly limited as long as it does not participate in the reaction, but generally includes ethers such as tetrahydrofuran, dioxane, and dimethoxymethane, and aprotic polar solvents such as dimethyl sulfoxide and dimethylformamide. The usage ratio of compound () and () may be appropriately selected, and it is generally preferable to use 1 mol to 2 molar equivalents of compound () with respect to compound (). The reaction temperature is also determined appropriately, but is usually preferably from -20°C to the reflux temperature of the solvent, and the reaction is generally sufficiently completed in about 1 to 24 hours.
The reaction is promoted by adding a catalytic amount of a crown ether such as 18-crown-6. <Method B> General formula [In the formula, R 1 and R 2 have the above meanings. ] By reacting the compound represented by the general formula with an oxidizing agent, [In the formula, n is an integer of 1 or 2, and R 1 and R 2 have the above meanings. ] The compound of the present invention can be produced. Various types of oxidizing agents can be used,
For example, peracids such as peracetic acid, perbenzoic acid, m-chloroperbenzoic acid, perphthalic acid, hydrogen peroxide, ozone, peroxides such as benzoyl peroxide, chromic acid,
Examples include metal oxides such as potassium permanganate, hypohalous acids such as sodium hypochlorite, and sodium metaperiodate. This reaction is preferably carried out in a solvent. The solvent is not particularly limited as long as it does not participate in the reaction, but water, alcohols such as methanol and ethanol, and halogenated hydrocarbons such as methylene chloride are used. The proportion of the oxidizing agent to be used is appropriately determined depending on the desired compound of the present invention and is not limited. For example, when producing a sulfoxide compound in which n is 1 in the general formula (), it is usually best to use an equimolar amount to the compound represented by the general formula (V), and if desired, a slight excess amount may be used. You can also do it. On the other hand, when producing a sulfone compound in which n is 2 in the general formula (), the proportion of the oxidizing agent used is about twice or more, usually about 2 to It is preferable to use 3 times the molar amount. The reaction temperature is determined appropriately, but is usually -40℃~
The boiling point temperature of the solvent is preferably within a range, and a reaction time of about 1 to 24 hours is generally sufficient. After completion of the reaction, the target compound can be easily isolated and purified by known methods such as extraction, recrystallization, column chromatography, etc. Hereinafter, the present invention will be explained in detail with reference to Reference Examples and Examples. Further, Table 1 shows the compounds of the present invention and their physicochemical properties. The compound numbers in each example correspond to the numbers listed in Table 1. Reference example 2-methyloxazole-4-carboxylic acid-t
- 7.32 g of butyl ester, 10.68 g of N-bromosuccinimide, 60 mg of benzoyl peroxide, and charcoal tetrachloride.
Pour into 200ml and reflux for 4 hours under light irradiation.
After cooling, insoluble matter is filtered off, and the filtrate is washed with water and dried over anhydrous sodium sulfate. The residue obtained by distilling off carbon tetrachloride is purified by silica gel column chromatography to obtain 4.35 g of 2-bromomethyl-oxazole-4-carboxylic acid t-butyl ester as a colorless oil. Boiling point 115-118℃/0.1mmHg 1 H-NMR (100MHz, CDCl 3 ) δ: 1.58 (9H, s, -COO-t-Bu) 4.47 (2H, s, -CH 2 -) 8.14 (1H, s, Proton at position 5 of oxazole ring) MS (M + ) 261 C 9 H 12 NO 3 Br Calculated value m/e 261.000 Actual value m/e 261.003 Example 1 670 mg of 50% sodium hydride, 27 ml of dry tetrahydrofuran 1.43 ml of benzenethiol is added dropwise to the suspension under ice cooling in a nitrogen stream. After stirring at the same temperature for 5 minutes, 3.33 g of 2-bromomethyl-oxazole-4-carboxylic acid t-butyl ester,
A solution of dried 18-crown-6 (100 mg) dissolved in 10 ml of tetrahydrofuran was added dropwise to the above reaction solution, and the mixture was further stirred at the same temperature for 1.5 hours. Tetrahydrofuran was distilled off, the residue was extracted with diethyl ether, the extract was dried over anhydrous sodium sulfate, the diethyl ether was distilled off, and the residue was purified by silica gel column chromatography to obtain an oily product. was crystallized from petroleum ether, and the crystals were recrystallized from ether-petroleum ether to give a melting point of 64.5~
3.1 g (yield: 81%) of 2-phenylthiomethyl-oxazole-4-carboxylic acid t-butyl ester (compound 1) was obtained as colorless fine needle-like crystals at 65.5°C. Example 2 Compounds 4 and 7 were obtained in the same manner as in Example 1 except that the raw materials were selected to obtain Compounds 4 and 7 listed in Table 1. Example 3 2.1 g of 2-bromomethyl-oxazole-4-carboxylic acid t-butyl ester was added to 3.2 g of sodium benzenesulfinate at room temperature under a nitrogen atmosphere.
20 ml of an acetonitrile solution containing 18-crown-6 (50 mg) was added dropwise and stirred for 8 hours. Acetonitrile was distilled off and the residue was extracted with methylene chloride and dried over anhydrous sodium sulfate. Methylene chloride was distilled off, ether was added to the residue, the crystals were collected by filtration, and recrystallized from ethanol to give 2-benzenesulfonylmethyl-oxazole-4-carboxylic acid-t as colorless fine needle-like crystals with a melting point of 180-181°C. -Butyl ester (compound 3) 1.99g (yield 76%) was obtained. Example 4 A solution of Compound 1 (846 mg) and 7 ml of methylene chloride was cooled with ice under a nitrogen stream, and a solution of 752 mg of 70% m-chloroperbenzoic acid and 14 ml of methylene chloride was added dropwise, followed by stirring at the same temperature for 30 minutes. Insoluble materials are removed by filtration, and the filtrate is washed with an aqueous sodium bicarbonate solution and dried over anhydrous sodium sulfate. After drying, methylene chloride was distilled off, the resulting residue was purified by silica gel column chromatography, and the resulting oil was crystallized from ether and recrystallized from ether-petroleum ether to give a product with a melting point of 129-130°C. 743 mg of 2-benzenesulfinylmethyl-oxazole-4-carboxylic acid t-butyl ester (compound 2) in the form of fine platelets
(yield 83%). Example 5 Compounds 5 and 8 were obtained in the same manner as in Example 4 except that the raw materials were selected to obtain Compounds 5 and 8 listed in Table 1. Example 6 2-(pyridyl-2-thiomethyl)-oxazole-4-carboxylic acid-t-butyl ester 584 mg
was dissolved in 5 ml of dichloromethane, cooled on ice under a nitrogen stream, 1.08 g of m-chloroperbenzoic acid was dissolved in 20 ml of dichloromethane, the solution was added dropwise, and the mixture was heated at the same temperature for 30 mL.
Stir for 5 minutes and then at room temperature for 5 hours. Insoluble matters are removed by filtration and the filtrate is concentrated. The resulting residue was purified by silica gel column chromatography and recrystallized from ethanol to give 2-(α-pyridinesulfonylmethyl)-oxazole-4-carboxylic acid in the form of colorless fine needles with a melting point of 173-174°C. 447 mg (yield 69%) of t-butyl ester (compound 6) was obtained. Example 7 Compounds 3 and 9 were obtained in the same manner as in Example 6 except that the raw materials were selected to obtain Compounds 3 and 9 listed in Table 1.
【表】【table】
Claims (1)
しくは2個含有し置換基として低級アルキル基を
有し若しくは有しない5又は6員環の芳香族複素
環基を、R2は低級アルキル基を、は0又は1
若しくは2の整数を意味する。〕で表わされるオ
キサゾール誘導体。[Claims] 1. General formula [In the formula, R 1 is an aryl group or a 5- or 6-membered aromatic heterocyclic group containing 1 or 2 nitrogen atoms and with or without a lower alkyl group as a substituent, and R 2 is a lower alkyl group. The group is 0 or 1
or an integer of 2. ] An oxazole derivative represented by
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21882582A JPS59108772A (en) | 1982-12-13 | 1982-12-13 | Oxazole derivative |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21882582A JPS59108772A (en) | 1982-12-13 | 1982-12-13 | Oxazole derivative |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59108772A JPS59108772A (en) | 1984-06-23 |
| JPH035391B2 true JPH035391B2 (en) | 1991-01-25 |
Family
ID=16725935
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP21882582A Granted JPS59108772A (en) | 1982-12-13 | 1982-12-13 | Oxazole derivative |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS59108772A (en) |
-
1982
- 1982-12-13 JP JP21882582A patent/JPS59108772A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS59108772A (en) | 1984-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS622585B2 (en) | ||
| JPS6157587A (en) | Condensed heterocyclic derivative and antiulcerative | |
| FR2566404A1 (en) | NOVEL 1,4-DIHYDROPYRIDINE DERIVATIVES, THEIR SALTS, PROCESS FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| US2921961A (en) | Unsaturated ethers of 2-acyl-4-aminophenols | |
| JPH035391B2 (en) | ||
| EP1218366B8 (en) | Method for producing cox-2 inhibitors | |
| GB1594450A (en) | 1,3-oxathiolane sulphoxides and their use in the preparation of 5,6-dihydro-2-methyl-1,4-oxathiin derivatives | |
| JP3101721B2 (en) | Method for producing aromatic fluorine compound | |
| JPS6129354B2 (en) | ||
| JPH04235976A (en) | Production of aralkylaminopyrimidine compounds | |
| JP3259206B2 (en) | Method for producing 2-substituted benzo [b] thiophene | |
| JP2678758B2 (en) | Novel propane derivative | |
| JPH07215952A (en) | Catechol derivative | |
| JPH05140157A (en) | Phenothiazine derivative | |
| JPH0144707B2 (en) | ||
| JP3534816B2 (en) | Method for producing methylthiobenzenes | |
| JPS59176234A (en) | P-nitrophenyl-3-bromo-2,2-diethoxy-propionate | |
| KR940006531B1 (en) | Process for preparation of pyridine derivatives | |
| JPH0216750B2 (en) | ||
| JPS61268650A (en) | Naphthoquinone derivative | |
| JPH03178959A (en) | Production of bisalkylsulfonomethyl ethers or bisarylsulfonoxymethyl ethers | |
| JPS5995232A (en) | Ketene-o,o-acetal and manufacture of ketene-o,n-acetal therefrom | |
| JPH0525876B2 (en) | ||
| JPH03215472A (en) | Novel 4-substituted-3,5-dimethylpicolinic acid compound and its production | |
| KR0135516B1 (en) | Process for the preparation of 3-phenylpyrrole derivatives |